Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Accelerate Fund is an Alberta-based early-stage venture capital and angel co-investment fund program that backs high-growth technology startups. The fund invests across multiple sectors, including life sciences, digital transformation, artificial intelligence, energy, and other emerging technologies, rather than operating as a drug developer or healthcare services company. Originally established in 2012 by Alberta Enterprise Corporation, the Accelerate Fund series has progressed through multiple vintages, with Funds II, III, and IV managed by Yaletown Partners. Its model typically matches or co-invests alongside angel and private investors to help Alberta startups reach the next financing milestone. While it has invested in health and medical innovation companies, Accelerate Fund itself is best characterized as an investor, not a biotech, pharma, or healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Accelerate Fund.